The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Open accessAbstract
The proliferation rate of vascular endothelium has been studied using repeated administrations of tritiated thymidine, given every 8 h for 1 week. Five experimental mouse tumours have been investigated and compared with placenta and with normal tissues. The large difference in labelling indices between tumour and normal endothelium that has previously been detected with single injections of ([3H]dT) is confirmed by these continuous labelling studies. The potential doubling time of the tumour endothelium is estimated to be between 2.4 and 13 days for the five tumours. Tpot for the placenta is at least as short. The turnover time of the normal tissue endothelium is estimated to be 20-2000 times longer (47-23,000 days) and does not seem to differ in slow turnover tissues e.g. lung and liver from that in tissues where the parenchymal cells are rapidly turning over e.g. jejunum or skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a tumor factor responsible for angiogenesis
Folkman, J., Merler, E., Abernathy, C., & Williams, G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.2.275 · Cited by 1,663
Lord, B. I. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.97 · Cited by 669
Hewitt, H. B., Blake, E. R., & Walder, A. S. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.37 · Cited by 474
Engerman, R. L., Pfaffenbach, D. D., & Davis (1967) · PubMed · Cited by 290
CELL LOSS FROM EXPERIMENTAL TUMOURS
Steel, G. G. (1968) · Cell Proliferation · doi:10.1111/j.1365-2184.1968.tb00318.x · Cited by 285
Endothelial cell proliferation as a novel approach to targeting tumour therapy
Denekamp, J. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.16 · Cited by 249
Self-citationTannock, I. F. (1970) · PubMed · Cited by 242
Endothelial-cell proliferation in experimental tumours
Denekamp, J., & Hobson, B. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.263 · Cited by 237
Self-citation(1972) · PubMed · Cited by 172
Analysis of the cell population kinetics of transplanted tumours of widely-differing growth rate.
Steel, G. G., Adams, K., & Barrett, J. C. (1966) · British Journal of Cancer · doi:10.1038/bjc.1966.90 · Cited by 155
Cited by
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Adipose tissue mass can be regulated through the vasculature
Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, R., & Folkman, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162349799 · Cited by 845
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.033 · Cited by 796
Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R., & D'Amore, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4544 · Cited by 757
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 724
The blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662
“The turnover of BMECs, measured as the mitotic index or the turnover time, is thought to be very low (Hobson and Denekamp, 1984; Ekstrand et al., 2008).”
BackgroundImproving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Khan, K. A., & Kerbel, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.9 · Cited by 657
Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2186 · Cited by 517
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495
Microvessel density is a prognostic indicator for patients with astroglial brain tumors
Leon, S. P., Folkerth, R. D., & Black, P. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<362::aid-cncr20>3.0.co;2-z · Cited by 481
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Kerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441
The organ microenvironment and cancer metastasis
Fidler, I. J. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700904.x · Cited by 426
Dudley, A. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006536 · Cited by 424
“In tumors, EC turnover greatly accelerates and may be 20–2000 times the rate in normal tissues (Hobson and Denekamp 1984).”
BackgroundSpontaneous transformation and immortalization of human endothelial cells
Takahashi, K., Sawasaki, Y., Hata, J.-I., Mukai, K., & Goto, T. (1990) · In Vitro Cellular & Developmental Biology · doi:10.1007/bf02624456 · Cited by 419
Tie2 Expression and Phosphorylation in Angiogenic and Quiescent Adult Tissues
Wong, A. L., Haroon, Z. A., Werner, S., Dewhirst, M. W., Greenberg, C. S., & Peters, K. G. (1997) · Circulation Research · doi:10.1161/01.res.81.4.567 · Cited by 417
Critical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
Denekamp, J. (1993) · The British Journal of Radiology · doi:10.1259/0007-1285-66-783-181 · Cited by 358
Self-citationMacrophage-derived angiogenesis factors
Sunderkötter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R., & Sorg, C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90077-y · Cited by 332
Vascular‐targeting therapies for treatment of malignant disease
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2004) · Cancer · doi:10.1002/cncr.20299 · Cited by 310
The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors
Moses, M. A. (1997) · STEM CELLS · doi:10.1002/stem.150180 · Cited by 298
Mailhos, C., Modlich, U., Lewis, J., Harris, A., Bicknell, R., & Ish-Horowicz, D. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.690207.x · Cited by 288
Thomas, K. A., Rios-Candelore, M., Giménez-Gallego, G., DiSalvo, J., Bennett, C., Rodkey, J., & Fitzpatrick, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6409 · Cited by 286
The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment
Sasaki, T., Hiroki, K., & Yamashita, Y. (2013) · BioMed Research International · doi:10.1155/2013/546318 · Cited by 285
Xia, P., Wang, L., Gamble, J. R., & Vadas, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34499 · Cited by 270
Defining adipose tissue-derived stem cells in tissue and in culture.
Lin, C., Xin, Z., Deng, C., Ning, H., Lin, G., & Lue, T. F. (2010) · PubMed · doi:10.14670/hh-25.807 · Cited by 264
Paweletz, N., & Knierim, M. (1989) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(89)80002-2 · Cited by 252
Linville, R. M., DeStefano, J. G., Sklar, M. B., Xu, Z., Farrell, A. M., Bogorad, M. I., Chu, C., Walczak, P., Cheng, L., Mahairaki, V., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.023 · Cited by 199
Benchmarking in vitro tissue-engineered blood–brain barrier models
DeStefano, J. G., Jamieson, J. J., Linville, R. M., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0117-2 · Cited by 142
A Review of String Vessels or Collapsed, Empty Basement Membrane Tubes
Brown, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100219 · Cited by 136
Lafargue, A., Degorre, C., Corre, I., Alves-Guerra, M.-C., Gaugler, M.-H., Vallette, F., Pecqueur, C., & Paris, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.019 · Cited by 131
Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro
Wick, N., Saharinen, P., Saharinen, J., Gurnhofer, E., Steiner, C. W., Raab, I., Stokic, D., Giovanoli, P., Buchsbaum, S., Burchard, A., et al. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2006 · Cited by 106
Metadata
- Authors
- Hobson, B., & Denekamp, J.
- Venue
- British Journal of Cancer
- Published
- 1984-04
- Volume
- 49
- Issue
- 4
- Pages
- 405-413
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2053938092
- Cited by
- 565
- References
- 22
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.